Lymphomas
A Phase 2, Open-Label Trial to Evaluate Safety of Epcoritamab monotherapy in Subjects with Relapsed or Refractory Diffuse Large B-cell Lymphoma and Follicular Lymphoma Grade 1-3a when Administered in the Outpatient Setting (M23-362)
- Details
ClinicalTrials.gov ID:
NCT05451810
Diagnosis Type:
NA
USOR Number:
- Address
520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001